FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

How to watch President Trump’s 2026 State of the Union address to Congress live

Climate groups sue Trump administration over EPA’s bombshell deregulation decision

Trump Admin Cancels Visas for 100,000 Foreign Nationals Who Don’t Meet American Standards

Developing: Bad News as DNA Results in Guthrie Kidnapping Come in to FBI

‘Devil in the Ozarks’ gets more prison time for escaping, now in supermax facility

Bald eagle floating on Hudson River ice rescued by NYPD

Minnesota Officials Forced to Sound the Alarms Over Fungal STD Outbreak

Watch: Whoopi Goldberg Rushes to Explain Why She Was in the Epstein Files Seeking to Use His Private Jet

Immigration judge blocks deportation of Columbia anti-Israel agitator

Sanders-endorsed Senate candidate knocked for alleged flip-flop to ‘have it both ways’ on key issue

Hollywood Star Arrested, Charged After Altercation: ‘Held Down Until Police Arrived’

NYC Board of Elections worker says ‘not my job to report anyone’ when asked about registering non-citizens

Gun store owner says FBI asked him to check firearm sales against list of names, pics in Guthrie case

Mike Lee calls Schumer’s ‘Jim Crow 2.0’ attack on voter ID bill ‘paranoid fantasy’

Palestinian activist accused of expressing desire to ‘kill Jews’ wins deportation case

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”